New Delhi : Diagnostic chain Dr Lal PathLabs raised over Rs 191 crore from anchor investors by selling shares at a price of Rs 550 apiece. The company’s initial public offer aims to raise up to Rs 638 crore.
Price band for the offer has been fixed at Rs 540-550 per share and the allotment to anchor investors has been done at the higher end.
At the price of Rs 550 apiece, the company would mop up Rs 191.40 crore from the anchor investors, including Reliance Life Insurance and Birla SunLife.
IBPS Releases Interim Allotment List For JA, PO, SO, & RRBs At ibps.in; Direct Link Here
RBI Holds Repo Rate Steady At 5.50%, Raises FY26 GDP Forecast To 6.8%
Markets Recover On Value Buying, RBI Policy Decision In Focus
US Government Shuts Down As Republicans, Democrats Fail To Break Impasse On Funding Bill
